Kai Kupferschmidt ✓

@kakape · Berlin, Germany · joined 08 Jun 2009

@kakape.bsky.social science journalist. molecular biologist. curious. writer at @sciencemagazine part of @pandemiapodcast, all things #blue

132 547Followers

2 003Following

24 018Posts total

320.3KViews on collected posts

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

11.3K30 Oct

11.3K

1.9K

6.6K

6.5K

44K

14.4K31 Oct

7.6K1 Nov

24.1K18 May

18919 May

6K27 May

20.6K

10.7K30 May

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

3.31%30 Oct

2.63%

8.47%

1.15%

1.97%

0.50%

0.83%31 Oct

0.33%1 Nov

0.60%18 May

0.53%19 May

0.00%

0.37%27 May

0.91%

1.34%30 May

Reactions — likes, reposts, replies and quotes — divided by views.

What the audience does

Likes76.3%3 434 in total

Reposts11.0%497 in total

Replies2.4%108 in total

Quotes0.8%37 in total

Bookmarks9.5%427 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

"Nearly 7 years after her first attempt to test Ebola prevention drugs, Jaspard is stunned by the sudden interest in the trial. “I've kept this project for all these years, despite the fact that a lot of people were saying it's not useful, you don't need to do this, go away,” she 10.7K views · 96 likes · 43 reposts · 2 replies 30 May 2026 One glimmer of hope in the Ebola response: Within hours of the outbreak in DRC being declared, researchers convened to prepare drug trials. A lot has changed on that front since the Ebola outbreak in West Africa a decade ago. But huge challenges remain… My story in 20.6K views · 130 likes · 49 reposts · 6 replies 27 May 2026 https://t.co/7Ge5a7v6Bb 6K views · 17 likes · 3 reposts · 0 replies 27 May 2026 @kakape @ScienceMagazine Call Fauci. His studies with the CDC showed the utility of remdesevir on ebola. When they killed everyone who took it, it became protocol for respiratory problems. Most are dead after 3-5 days.... STILL PROTOCOL!!! 90 views · 0 likes · 0 reposts · 0 replies 19 May 2026 @kakape @JeremyKonyndyk @ScienceMagazine Thanks Kai. Good article. What about an mRNA vaccine? 189 views · 1 likes · 0 reposts · 0 replies 19 May 2026 There is a LOT going on as researchers and public health experts are racing to respond to the #Ebola Bundibugyo outbreak in DRC and Uganda before it grows bigger. My story in @ScienceMagazine is here:  https://t.co/aVam5zVDCw 24.1K views · 89 likes · 48 reposts · 4 replies 18 May 2026 @NewsfromScience @katestarbird @uwcip Final story is up now too. It’s about inoculation, its roots in Cold War psychology research and what if anything we can expect from this and other psychological interventions… https://t.co/I5oEGcBa59 7.6K views · 18 likes · 2 reposts · 3 replies 01 Nov 2024 @NewsfromScience @katestarbird @uwcip Second story from my trio on misinformation research covers what I see as the 5 biggest challenges facing the field. It is up here now: https://t.co/08QKJ03Nma 14.4K views · 79 likes · 28 reposts · 7 replies 31 Oct 2024 The first story is up now on @NewsfromScience: It’s a look at the work of @katestarbird and her team at @uwcip, who study rumors at the University of Washington, specifically rumors around the US elections. https://t.co/kggCBxEodQ 44K views · 170 likes · 35 reposts · 10 replies 30 Oct 2024 Those stories are coming out this week in @ScienceMagazine and I will try and do something I haven’t done in a while and delve deeper in a few threads. 6.5K views · 122 likes · 3 reposts · 2 replies 30 Oct 2024 (oops, broke the thread. It's been too long clearly. lol Let me repost the rest below) 6.6K views · 74 likes · 1 reposts · 1 replies 30 Oct 2024 @kakape We could start with the disinformation that the COVID pandemic is over. 1.9K views · 146 likes · 11 reposts · 3 replies 30 Oct 2024 It’s been an interesting experience in turns fascinating and frustrating and when I went back to full-time science writing earlier this year I decided to try and put at least some of what I’ve learnt into words. 11.3K views · 283 likes · 10 reposts · 4 replies 30 Oct 2024 I ended up spending almost a year at MIT as a Knight Science Journalism Fellow (@KSJatMIT) to try and understand misinformation/disinformation better, to - I hope - be a better infectious disease journalist. 11.3K views · 354 likes · 16 reposts · 5 replies 30 Oct 2024 I’ve reported on infectious diseases for 15 years, but during the covid-19 pandemic and even more during the global outbreak of mpox clade IIb, I was shocked by the amount of misinformation I was seeing. Misinfo had always been part of any outbreak, but this felt different. 155.2K views · 1.9K likes · 248 reposts · 61 replies 30 Oct 2024

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Latest posts

Similar accounts